Dynavax to Present at UBS 2007 Global Life Sciences ... (tis C therapeutic program. While the NIH...)

(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Na...elopingandcommercializingnovelpainmanagementtherap...hiefExecutiveOfficer,isscheduledtopresentatthe21st...ember1-2,2009atTheNewYorkPalaceHotelinNewYork,NewY...ncialOfficer,willbeavailabletorespondtoquestionsdu...

(Date:11/24/2009)...4/PRNewswire/--BlueMarbleEnergyCorp.announcedtoday...ty(OPDA)wererecentlyawarded$2millionbyWashingtonSt...private/publicpartnershiptoconstructthestate,sfirs.... ,, "Thisinvestmentwillsignificantlyspeedthede...LincolnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie...

(Date:11/24/2009)...cyendpointhasbeenmetforpatientswithadvanced-stage,...v.24/PRNewswire-FirstCall/-AEternaZentarisInc.(NAS...ceuticalcompanyfocusedonendocrinetherapyandoncolog...dywithitstargetedcytotoxicpeptideconjugate,AEZS-10...tendometrialcancer.Inapersonalizedhealthcareapproa...

(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...

Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2 NeurogesX to Present at Piper Jaffray Health Care Conference 3 Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3 AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2 Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3

[0] NeurogesX to Present at Piper Jaffray Health Care Conference [0] Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board [0] AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer [0] Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease

...ORONTO, Jan. 29 /PRNewswire-FirstCall/ - ARIUS Res...scovering and developing the next wave of,antibody...perational,results for the fourth quarter and fisc...as a critical year in our development, highlighted...re-IND programs for our lead drug,candidates, our ...

... CHAMPAIGN, Ill. Carbon nanotubes have a sound f... who built the worlds first all-nanotube transisto...ch nanotube devices provide all of the active func...t steps toward the practical implementation of car...tronics and other related applications, said John ...

..., Troy, N.Y. Researchers at Rensselaer Polytechn...new inexpensive, quick-drying polymer that could l...in semiconductor manufacturing and computer chip p...nce and cost savings for conventional photolithogr...poxy siloxane (PES), should also enable a new gene...

ARIUS announces fourth quarter and year-end fiscal 2007 financial results New kind of transistor radios shows capability of nanotube technology New polymer could improve semiconductor manufacturing, packaging

(Date:11/23/2009)...community-associated strain of the deadly superbug...st common antibioticsposes a far greater health th...nto hospitals, according to a study in the Decembe...e new threat is easily picked up in fitness center...sed the overall burden of MRSA within hospitals, t...

(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...

(Date:11/23/2009)... than 160 participants gathered this week for the ...TIATIVE conference. This year,s topic, "Synthetic ...and medical researchers to explore the engineering...erging field of synthetic biology. , Bonnie L. B...n University and this year,s conference chair, cha...

Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2 Time of day matters to thirsty trees, U of T researcher discovers 2 Synthetic biology offers new opportunities for interdisciplinary collaboration 2 AbbeyMoor Medical Receives FDA Approval for Design Improvements to The Spanner 28TM 29 Prostatic Stent 50785 1 CareMedic and Cincom Sign OEM Technology Partnership for Healthcare Solution 50783 1 CareMedic and Cincom Sign OEM Technology Partnership for Healthcare Solution 50783 2 Research Reveals Clues to Breast Cancers Spread 50781 1 Research Reveals Clues to Breast Cancers Spread 50781 2

[2] New study finds MRSA on the rise in hospital outpatients [1] Time of day matters to thirsty trees, U of T researcher discovers [0] Synthetic biology offers new opportunities for interdisciplinary collaboration

...With an incredible lifespan of up to 250 years the...ng the longest-lived of all animals, but how it ob...- to keep going for this long has been a mystery. ...ss online journal PLoS Biology, Erik Cordes and co...waste sulfate not up into the ocean but down into ...

...For the first time, scientists have replicated hep...y to replicate HCV in cell culture will allow rese... of this virus and to test potential antiviral com...ver disease that results from infection with HCV. ...nd Digestive and Kidney Diseases (NIDDK), one of t...

...When the most common adult leukemia in the United ...l of Medicine (NEJM) in 1995, it was seen through ... As such, the journal recently invited three of th...leukemia (CLL) to write an authoritative update co...ity,s knowledge of CLL that has occurred over the ...

Other Biology News: The secret to longevity in tubeworms 2 Scientists Replicate Hepatitis C Virus in Laboratory 2 Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine 2

The secret to longevity in tubeworms Scientists Replicate Hepatitis C Virus in Laboratory Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine

RAOSMC (R354-05) from European Collection of Cell Cultures (ECACC)

BlueView Nucleic Acid Stain from Sigma-Aldrich

REK (R102-05) from European Collection of Cell Cultures (ECACC)

... long been a molecule of fascination, being the pr...tive peptides such as ACTH, -Lipotrophin (-LPH), -...-MSH) and more. It is also a very well-conserved m...including those "living fossils", the lungfish. Th...

Biology Products:

RAOSMC (R354-05) from European Collection of Cell Cultures (ECACC)BlueView Nucleic Acid Stain from Sigma-Aldrich REK (R102-05) from European Collection of Cell Cultures (ECACC)Pro-OpioMelanoCortin (POMC) ELISA Kit from IDS Ltd

Dynavax to Present at UBS 2007 Global Life Sciences ...(tis C therapeutic program. While the NIH...)